The goal of the Breast Oncology Program is to support and stimulate basic, clinical, and population research in breast cancer and to facilitate the translation of these findings into improved cancer management and control.
The Cancer Control Program focuses on social, behavioral, communications, and health policy research, integrating it with cancer research across the spectrum from the basic to the population sciences.
The goal of the Cancer Genetics Program is to elucidate the genetics of tumor susceptibility, tumorigenesis, and progression, and to use this information clinically to improve cancer management.
The mission of the Cancer Immunology Program is to understand the molecular basis and dynamic relationship between the immune system and cancer in order to translate this knowledge into novel and improved therapeutics.
The Experimental Therapeutics Program brings together basic cancer biologists and physician scientists to discover and test novel compounds and treatment strategies for cancer.
The Hematopoietic Malignancies Program aims to improve the outcome of patients with leukemia, lymphoma, and multiple myeloma through basic and translational laboratory studies and clinical investigation.
The Neurologic Oncology Program aims to impact the diagnosis and treatment of brain cancer using a team approach.
The goal of the Pediatric Malignancies Program is to improve the outcome for children with cancer by investigating links between normal development and the aberrant signaling networks of childhood malignancies, and to leverage these genetic networks to identify new therapeutic targets that we integrate into innovative clinical trials.
The Prostate Cancer Program promotes interdisciplinary research to support the development of novel management and intervention strategies to improve the lives of men with prostate cancer.
The goal of the Tobacco Control Program is to eradicate the use of tobacco and tobacco-induced cancer and other diseases worldwide.